Clinical Trial Update: Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing optimized exposure of beta-lactam antibiotics in critically ill patients with sepsis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Beta-lactam antibiotics

Snippet

Sponsor: Erasmus Medical Center | Conditions: Sepsis - to Reduce Mortality in the Intensive Care Unit, Sepsis | Phase 4 | Status: RECRUITING